VNOTES and Vaginal Hysterectomy for Benign Indications
- Conditions
- HysterectomyHysterectomy, Benign Uterine DiseasesHysterectomy, Vaginal
- Registration Number
- NCT06776718
- Lead Sponsor
- Dr. Lutfi Kirdar Kartal Training and Research Hospital
- Brief Summary
This study aimed to compare the surgical outcomes of Vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) and conventional vaginal hysterectomy (VH) for benign gynecological conditions.
A prospective analysis will conducted at a tertiary hospital from January 2025 to February 2025. Patients aged 40-80 who underwent hysterectomy for benign indications will included. Outcomes will assessed included surgical outcomes, Visual Analog Scale (VAS) pain scores, and complication rates.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- Female
- Target Recruitment
- 100
- aged between 40 and 80 years
- undergo hysterectomy for benign gynecological conditions
- history of urogynecological surgery (including pelvic organ prolapse surgery and mid-urethral sling procedures),
- suspected gynecologic malignancies,
- endometriosis,
- tubal-ovarian abscesses,
- pelvic organ prolapse exceeding grade 2,
- individuals who refused to participate in the study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method the duration of surgery The time from the beginning to the end of the operation İnterval from initial incision to the completion of vaginal cuff closure (minute)
- Secondary Outcome Measures
Name Time Method Hospitalization time through study completion, an average of 1 month Time from surgery to discharge (hours)
VAS score postoperative 6th and 24 th hour Visual Analog Score for pain at postoperative 6th and 24 th hour (0-10)
Uterin volume through study completion, an average of 1 month Uterine volume is quantified in milimeters based on measurement of pathological specimens, calculate using the formula (Uterine volume (ml)= (anterior-posterior diameter)\* (sagital diameter) \* (transverse diameter) \* 0,0005236
Re-admission within 1 month after discharge Re-admission to hospital after discharge (yes/no)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Kartal Dr Lütfi Kirdar City Hospital
🇹🇷İstanbul, Turkey